Skip to main content

Closed

ZBIO: Zenas BioPharma, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-61.5%

Financially safe

Stretched

Debt / equity1.05×

Interest coverage-63.8×

Current ratio11.94×

Zenas BioPharma, Inc.

ZBIONASDAQ Global Select·USD·Closed

Zenas BioPharma, Inc.

ZBIONASDAQ·USD·Closed

$31.44

−2.57%

$31.44

−$0.83 (2.57%)

52W Range

58thpctl

Volume

0.55×avg

Mkt Cap

1.98BUSD

P/E

-3.5TTM

Div Yield

–ann

52W Range

58thpctl

Volume

0.55×avg

Market Cap

1.98BUSD

P/E Ratio

-3.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings